The next few years may see the appearance of viable treatments for those suffering from life-threatening peanut allergies, if the findings of two new studies are put into practice on a wide scale.
According to a report in the New York Times, a group of 33 children in one study — conducted by Duke University and an Arkansas children’s hostpital — received daily doses of peanut in a supervised medical setting. The amount of peanut administered to the children was gradually increased, from a thousandth of a peanut at the beginning of the process to about 15 peanuts a day at the end. From the story:
Most of the children are tolerating the therapy without developing allergic reactions, and five stopped the treatment after two and a half years because they could now tolerate peanuts in their regular diet. But four children dropped out because they could not tolerate the treatment.
In a related study of just 18 children, the researchers gave the treatment to 12 children and a placebo powder to 6. After 10 months, the children were given a medically supervised test exposing them to peanuts. In the placebo group, the children developed symptoms after ingesting the equivalent of one and a half peanuts. In the treatment group, the children tolerated 15 peanuts without symptoms.
Far more study is needed before the treatment can be used outside of a research setting, Dr. Burks said. The Duke/Arkansas study plans to enroll at least 80 children in the next few years to assess the treatment.
To learn more about food allergies and how to care for children in your community who experience them, please attend The Hudson Valley Food Allergy Support Group’s medical panel on the subject tomorrow, March 17. The event will be hosted at the Beacon High School, at 101 Matteawan Rd, and food and refreshments will be served. Please arrive by 10am.
